Underappreciated opportunities for high-density lipoprotein particles in risk stratification and potential targets of therapy.
Underappreciated opportunities for high-density lipoprotein particles in risk stratification and potential targets of therapy. Cardiovasc Drugs Ther. 2015 Feb; 29(1):41-50.